<DOC>
	<DOCNO>NCT02249104</DOCNO>
	<brief_summary>The goal study evaluate complete topical acne regimen consist prescription acne medication ( Epiduo® Gel ) acne-specific cleanser ( Cetaphil® DermaControl™ Foam Wash ) moisturizer sunscreen ( Cetaphil® DermaControl™ Moisturizer SPF 30 ) safety , efficacy patient satisfaction student athletes acne vulgaris .</brief_summary>
	<brief_title>A Treatment Regimen Student Athletes With Mild Moderate Acne Vulgaris</brief_title>
	<detailed_description>The overall purpose study demonstrate lesion count reduction baseline , subject satisfaction , compliance regimen adapalene BPO use conjunction foam wash moisturizer sunscreen student athlete . The study hypothesis regimen would reduce total lesion count ( inflammatory noninflammatory ) relative baseline . The objective study evaluate change lesion count ( total , inflammatory , noninflammatory ) subject use CoMMPlete regimen .</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Adapalene</mesh_term>
	<mesh_term>Adapalene , Benzoyl Peroxide Drug Combination</mesh_term>
	<mesh_term>Benzoyl Peroxide</mesh_term>
	<criteria>1 . Male female age 12 year older actively participate one 14 Texas University Interscholastic League ( UIL ) sanction athletic activity baseline visit ( Baseball ; Basketball ; Cross Country ; Football ; Golf ; Soccer ; Softball ; Swimming Diving ; Team Tennis ; Tennis ; Track Field ; Volleyball ; Wrestling ) . 2 . Subjects agree photograph visit . 3 . Diagnosed acne vulgaris BCD eligible treatment Epiduo® ( adapalene benzoyl peroxide ) Gel 0.1 % /2.5 % per PI . 4 . Female subject must negative urine pregnancy test ( UPT ) Baseline/Visit 1 , must willing test perform clinic , must agree practice one form effective method nonhormonal contraception duration study include : abstinence , IUD ( insert 30 day prior baseline ) , doublebarrier method , bilateral tubal ligation , vasectomized partner ( least 90 day prior baseline ) . 5 . A minimum 20 50 inflammatory ( papule pustule ) lesion face ( exclude nose ) minimum 30 100 noninflammatory lesion ( open comedo close comedo ) face ( exclude nose ) . 6 . Agree use provide study product acne treatment , facial wash facial moisturizer duration study . 7 . Agree refrain temporary permanent tattoo , paint , facial art ( include , limited piercings ) , cosmetic procedure device ( include , limited facial peel , microdermabrasion Clarisonic® ) face duration study . 8 . Subjects aged 1217 must willing read provide write informed consent/assent conjunction parent/legal guardian able willing read provide write consent prior study related procedure subject age 18 old must willing read provide write informed consent prior study related procedure . 9 . Subjects apprise Health Insurance Portability Accountability Act 1996 ( HIPAA ) applicable state Bill Rights willing share personal information data , verify sign write authorization Screening . 10 . Subjects must willing able attend study visit fulfill dose requirement . 11 . Subjects able follow study instruction likely complete require visit . In particular , subject must agree adhere visit schedule compliant treatment regimen . 1 . Subjects nodules cyst . 2 . Female subject pregnant , nurse plan pregnancy study . 3 . Subjects facial hair , abnormal pigment vascular skin lesion , abnormal skin pigmentation , body art ( tattoo , permanent temporary ) face , could interfere subsequent evaluation dermal responsiveness . 4 . Subjects systemic dermatological disorder , know history allergy medical condition , opinion principal investigator/BCD , could interfere conduct study , interpretation result increase risk adverse reaction . 5 . Subjects know allergy ingredient list study product label ( refer study product‟s PI and/or current labelling ) . 6 . Subjects participate another interventional , investigational drug device research study within 30 day enrollment . 7 . Study site staff sponsor staff , relatives site staff sponsor , individual would access clinical study protocol . 8 . Subjects washout period le 1 week overthecounter topical acne treatment ( active ingredient Benzoyl Peroxide , Salicylic Acid , Sulfur Resorcinol ) , prescription topical acne treatment topical corticosteroid , use cosmetic device ( Clarisonic® similar ) less 4 week topical retinoids . 9 . Subjects washout period le 4 week systemic prescription acne treatment systemic corticosteroid le 24 week oral retinoids . 10 . Subjects current sunburn , eczema , atopic dermatitis , perioral dermatitis , rosacea , topical condition area treat . 11 . Subjects risk term precaution , warning , contraindication ( refer study product‟s PI current labelling ) . 12 . Subjects foresee unprotected intense UV exposure study ( mountain sport , UV radiation , sunbathe , etc. ) . 13 . Subjects visible skin condition facial hair could interfere evaluation . 14 . Subjects take plan take topical systemic medication treat acne course study . 15 . Subjects take medication , supplement , nonprescription treatment , opinion principal investigator/BCD , could interfere test result include regimen steroidal/nonsteroidal antiinflammatory drug , antihistamine , anabolic steroid . 16 . Subjects currently treatment asthma diabetes ( insulindependent ) . 17 . Subjects plan surgical cosmetic procedure face course study . 18 . Subjects history procedure microdermabrasion , chemical peel , intense pulse light , filler , Botox® , laser , photodynamic therapy , red blue light therapy , etc . last 90 day .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>